Literature DB >> 28746432

Late onset multiple sclerosis: concerns in aging patients.

Claudia Beatriz de Campos Lotti1, Acary Souza Bulle Oliveira1, Denis Bernardi Bichuetti1, Isac de Castro2, Enedina Maria Lobato Oliveira1.   

Abstract

Late onset multiple sclerosis (LOMS) is when the first symptom starts after 50 years of age, representing 4.5% of multiple sclerosis (MS) patients. This study describes the clinical characteristics of patients with LOMS followed at a specialized MS center in São Paulo. Data was obtained from medical records of 742 patients with MS. The LOMS frequency was 4.18%, median age at onset was 54 years and the predominant disease course was primary progressive (64.3%). The patients reached the disability landmarks of EDSS grades 3.0, 6.0 and 7.0 in the following proportion and time: EDSS 3.0: 77.42% of patients in 3.7 years; EDSS 6.0: 58.06% in 5.1 years and EDSS 7.0: 32.26% in 5.7 years. The comparative analysis with a matched control group of patients with early onset MS showed that late onset, associated with a progressive course, were predictors of reaching EDSS 3.0 and 6.0 in a shorter time.

Entities:  

Mesh:

Year:  2017        PMID: 28746432     DOI: 10.1590/0004-282X20170070

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  4 in total

1.  Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis.

Authors:  Mehdi Rezaee; Mohammad Hossein Morowvat; Maryam Poursadeghfard; Armin Radgoudarzi; Khosro Keshavarz
Journal:  BMC Health Serv Res       Date:  2022-01-28       Impact factor: 2.655

2.  Cognition and disease characteristics in adult onset versus late onset multiple sclerosis.

Authors:  Rachel Butler Pagnotti; Le H Hua; Justin B Miller
Journal:  Mult Scler       Date:  2021-08-19       Impact factor: 5.855

3.  Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.

Authors:  Zahra Salehi; Amir Almasi-Hashiani; Mohammad Ali Sahraian; Fereshteh Ashtari; Seyed Mohammad Baghbanian; Nazanin Razazian; Abdorreza Naser Moghadasi; Asghar Bayati; Amir Reza Azimi; Nahid Beladimoghadam; Mohammad Hossein Harirchian; Maryam Poursadeghfard; Samira Navardi; Reza Shirkoohi; Hora Heidari; Mehran Ghaffari; Sharareh Eskandarieh
Journal:  BMC Neurol       Date:  2022-03-05       Impact factor: 2.474

4.  Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.

Authors:  Omid Mirmosayyeb; Serge Brand; Mahdi Barzegar; Alireza Afshari-Safavi; Nasim Nehzat; Vahid Shaygannejad; Dena Sadeghi Bahmani
Journal:  J Clin Med       Date:  2020-05-02       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.